Label: GUAIFENESIN tablet
- NDC Code(s): 11673-539-02
- Packager: TARGET CORPORATION
- Category: HUMAN OTC DRUG LABEL
Drug Label Information
Updated November 18, 2024
If you are a healthcare professional or from the pharmaceutical industry please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active ingredients (in each extended-release bi-layer tablet)
- purpose
- Uses
- Warnings
- Ask a doctor before use if you have
- Stop use and ask a doctor if
- If pregnant or breast-feeding,
- Keep out of reach of children.
-
Directions
do not crush, chew, or break tablet
take with a full glass of water
this product can be administered without regard for timing of meals
adults and children 12 years of age and over: 1 or 2 tablets every 12 hours. Do not exceed 4 tablets in 24 hours.
children under 12 years of age: do not use - Other information
- Inactive ingredients
- Questions?
- Principal display panel
-
INGREDIENTS AND APPEARANCE
GUAIFENESIN
guaifenesin tabletProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:11673-539 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN 600 mg Inactive Ingredients Ingredient Name Strength SODIUM STARCH GLYCOLATE TYPE A (UNII: H8AV0SQX4D) HYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4) MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) MAGNESIUM STEARATE (UNII: 70097M6I30) CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED) (UNII: Z135WT9208) Product Characteristics Color white Score no score Shape OVAL Size 16mm Flavor Imprint Code G;600 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:11673-539-02 20 in 1 BLISTER PACK; Type 0: Not a Combination Product 08/01/2024 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA213420 08/01/2024 Labeler - TARGET CORPORATION (006961700)